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Cisplatin [cis-diamminedichloroplatinum (II)] is one of the most effective single agents employed in the treatment of carcinoma of the urinary bladder (Harker & Torti, 1983) . A major obstacle in the clinical use of this agent is, however, the development of resistance (Frei et al., 1985) . Since DNA is widely believed to be the critical target for the cytotoxic action of platinum co-ordination complexes (Roberts & Thomson, 1979) we have compared DNA damage and repair in two human bladder tumour cell lines with differential sensitivities to cisplatin.
The continuous cell lines T24 and RT112 were both derived from transitional cell carcinomas of the human bladder and were grown as monolayers using conditions described elsewhere (Hepburn et al., 1985) . The T24 cells were almost twice as sensitive (IC, 7.6pg/ml) as RT112 cells (ICw 14.4pg/ml) after a 1 h exposure to a cytotoxic range of concentrations of cisplatin. DNA-DNA interstrand cross-links (ISL) were quantified by alkaline filter elution (Kohn er a/., 1981) as a proteinase-resistant reduction in the rate of elution of DNA containing X-ray-induced single-strand breaks (600 rad, 500 rad/ min., Pantak Ltd, Slough, U.K.). ISL were measured 0, 5, 14 and 24 h after a 1 h exposure to the drug. The concentrations of cisplatin used were 5, 10 and 20pg/ml. The number of ISL were corrected for any drug-induced single-strand breaks by employing drug-treated unirradiated controls. Peak cross-linking occurred at 5 h for T24 cells, and at 14h for RT112 cells. A subsequent decrease in ISL at 24 h in both cell lines was attributed to cross-link removal since there was no microscopic evidence of gross cell death. No difference in the rate of loss of ISL was observed between either cell line, but the number of ISL was approximately twice as great in T24 cells as in the RTl12 cells at all time points. At a cisplatin concentration of 20pg/ml the peak levels of ISL were In addition to measuring drug-induced DNA crosslinking, a comparison was made of the effect of cisplatin on semi-conservative DNA synthesis in both cell lines. Cells were template-labelled for 24h with 25nCi of methyl-[14C]thymidine (55 mCi/mmol, Radiochemical Centre, Amersham, U.K.)/ml followed by exposure to 1Opg of cisplatin/ml for 1 h. At various times after drug removal the incorporation of tritiated thymidine (10 pCi/ ml, 25 Ci/mmol, Radiochemical Centre) was monitored after a 1 h pulse by precipitating the DNA onto glassfibre filters using 4% perchloric acid at 4°C. The ratio of 'H/I4C remaining on the filter was established for treated cells and expressed as a percentage of the control. The use of a I4C-template label obviated the need to ascertain cell numbers before DNA precipitation. A rapid inhibition in thymidine incorporation occurred in both cell lines, with no detectable recovery 24 h after a 1 h exposure to cisplatin. The nadir of DNA synthesis occurred by 3 h at 14.3 f 1.6% and 29.0 _+ 6.9% of control values for T24 and RTI 12 cells respectively. Reduction in thymidine incorporation could not be accounted for by any significant decrease in the uptake of the precursor into the acid-soluble pool.
In conclusion, two human bladder tumour continuous cell lines had an approximate two-fold difference in sensitivity to the cytotoxic effects of a 1 h exposure to cisplatin. This treatment induced approximately twice as many ISL in the more sensitive T24 cell line when compared with the RTI 12 cells. No difference was detected, however, in the rate of cross-link removal for either cell line. In addition, T24 cells were more sensitive than RTl12 cells in terms of inhibition of semi-conservative DNA synthesis to a significantly greater extent (approximately two-fold). These differences might reflect a reduced uptake and/or binding of cisplatin to the DNA of the RTI 12 bladder tumour cells and experiments are underway to investigate these possibilities. , 1982) . In an effort to discover the underlying basis for these clinical observations a human tumour continuous cell line (HN-I), derived from an epithelioid carcinoma of the tongue, was treated with fractionated X-irradiation in vitro and the resultant sub-line (HN-1 /DXR) was shown to express resistance to etoposide (VP-16-21 3) and vincristine (Hill & Bellamy, 1984) .
VP-16-213, a semi-synthetic derivative of podophyllotoxin, has a broad spectrum of clinical anti-tumour activity, proving one of the most active single agents in the treatment of small-cell carcinoma of the lung and has activity as second line therapy of germ-cell tumours in combination with other drugs (O'Dwyer et al., 1985) . Its mechanism of cytotoxicity appears to involve DNA strand breakage (Loike & Horwitz, 1976; Long et al., 1984; Wozniak & Ross, 1983) and subsequent chromosomal aberrations (Huang et al., 1973) brought about by a poisoning of DNA topoisomerase I1 (Ross et al., 1984) .
Vincristine has also shown considerable clinical antitumour activity in combination with other drugs in a variety of human tumours, including those of the head and neck (Price & Hill, 1982) . It has considerable antimitotic activity in vitro, and its cytotoxicity is thought to be manifested in an inhibition of tubulin polymerization (Watanabe & West, 1982) . Resistance to vincristine in vitro has been associated predominantly with reduced cellular accumulation of drug (reviewed by Beck, 1984) .
The biochemical mechanisms associated with these altered drug responses after X-irradiation are being studied in order to determine whether the preponderant mechanism differs depending upon the agent and procedure employed to induce drug resistance. We have therefore compared the X-irradiated sub-line (HN-I/ DXR) with a line in which drug resistance has been established by continuous exposure of the parental HN-1 cells to VP-16-2 13 (HN-I/VP-2). This line also expresses cross-resistance to vincristine.
The following parameters have been studied: drug uptake, glutathione levels, and extent of DNA damage after drug treatment.
Drug responses were established by assessing cell survival by colony formation in soft agar (Courtenay & Mills, 1978) . ICso values for the HN-1, HN-1/DXR and HN-I/VP-2 cells were 3.2, 5.0 and 9 . 7~~ respectively after a 1 h exposure to VP-16-2 13. The order of resistance These data indicate that different mechanisms of resistance may be implicated in these differently derived resistant cell lines. Further studies using isolated nuclei should reveal whether the alteration in DNA damage in the drug-treated sub-line is independent of drug uptake through the plasma membrane, a finding that would suggest that resistance to VP-16-213 in these cells may be associated with reduced activity of DNA topoisomerase I1 (Pommier e f al., 1985) .
16-213, 1 h).
